Search results for "Cortex"

showing 10 items of 1827 documents

An uncommon presentation of eosinophilic granulomatosis with polyangiitis: a case report

2013

Introduction Eosinophilic granulomatosis with polyangiitis is a rare and potentially fatal disease if not readily diagnosed. Cerebral involvement is extremely rare and clinical presentation as hemorrhagic stroke is even rarer. Case presentation A 58-year-old Caucasian man was admitted to our medical unit because of a computed tomography-diagnosed hemorrhagic stroke with right-sided hemiparesis and fever. A chest computed tomography scan also revealed multiple bilateral pulmonary infiltrates; coronary artery, and carotid and left vertebral artery calcifications were also observed. Empiric antimicrobial therapy with cephalosporins was promptly undertaken; low-molecular-weight heparin was intr…

MalePathologymedicine.medical_specialtyChurg-Strauss polyangiitisSettore MED/09 - Medicina Internaeosinophilic granulomatosiCase ReportSelf MedicationChurg-Strauss SyndromeCoronary AngiographyAdrenal Cortex HormonesEosinophilicMedicineHumansChurg–Strauss syndromeCorticosteroidsLeukocytosisSelf-medicationStrokeLungAnti-neutrophil cytoplasmic antibodyMedicine(all)medicine.diagnostic_testbusiness.industryEosinophilic granulomatosis with polyangiitisGeneral MedicineCerebral InfarctionMiddle AgedSubarachnoid Hemorrhagemedicine.diseaseCoronary arteriesStrokemedicine.anatomical_structureAngiographymedicine.symptombusinessGranulomatosis with polyangiitisImmunosuppressive AgentsSystemic vasculitis
researchProduct

3-Acetylpyridine-induced degeneration and regeneration in the adult lizard brain: a qualitative and quantitative analysis

1997

Abstract The neurotoxin 3-acetylpyridine (3AP) produces highly selective neuronal damage in specific areas of the lizard brain. Following 3AP intoxication, proliferation and migration of replacement neurons born in the ventricular walls lead to regeneration of the lesioned areas. Earlier studies established the time course of 3AP-induced degeneration and subsequent regeneration in the medial cerebral cortex of adult lizards (Font, E., Garcia-Verdugo, J.M., Alcantara, S. and Lopez-Garcia, C., Neuron regeneration reverses 3-acetylpyridine-induced cell loss in the cerebral cortex of adult lizards, Brain Res. , 551 (1991) 230–235 [13] ). Complementary to our previous studies, we now provide a q…

MalePathologymedicine.medical_specialtyDendritic spinePyridinesNeurotoxinsBiologyTransneuronal degenerationsymbols.namesakeCortex (anatomy)medicineAnimalsMolecular BiologyCell NucleusCerebral CortexNeuronsCerebrumGeneral NeuroscienceNeurogenesisBrainLizardsDNAAnatomyNerve Regenerationmedicine.anatomical_structureCerebral cortexNerve DegenerationNissl bodysymbolsFemaleNeurology (clinical)NeuronThymidineDevelopmental BiologyBrain Research
researchProduct

Time-course of GDNF and its receptor expression after brain injury in the rat

2008

Abstract The aim of the present work was to perform, by in situ hybridization, a time-course analysis of the glial cell line-derived neurotrophic factor (GDNF) and its receptor mRNA expression in two models of brain injury in the rat: (a) excitotoxic lesion by ibotenic acid injection in the hippocampal formation; (b) mechanical lesion by needle insertion through the cerebral cortex including the white matter of the corpus callosum. The time-course analysis, ranging from 6 h to 8 days, showed that the GDNF and its receptor (RET, GFRα-1 and GFRα-2) mRNA expressions were differentially up-regulated in both models of lesion. This in vivo regulation of the GDNF and its receptor mRNA expression i…

MalePathologymedicine.medical_specialtyGlial Cell Line-Derived Neurotrophic Factor ReceptorsTime FactorsReceptor expressionCentral nervous systemBiologyHippocampal formationSettore BIO/09 - FisiologiaLesionchemistry.chemical_compoundNeurotrophic factorsGlial cell line-derived neurotrophic factormedicineAnimalsGlial Cell Line-Derived Neurotrophic FactorRNA MessengerRats WistarIbotenic AcidGeneral NeuroscienceGDNF RET GFRalfa-1 GFRalfa-2 Brain injury In situ hybridizationRatsmedicine.anatomical_structureGene Expression Regulationnervous systemchemistryCerebral cortexBrain Injuriesbiology.proteinAutoradiographymedicine.symptomIbotenic acidNeuroscience Letters
researchProduct

Moderate controlled cortical contusion in pigs: effects on multi-parametric neuromonitoring and clinical relevance.

2004

Over the last decade, routine neuromonitoring of ICP and CPP has been extended with new on-line techniques such as microdialysis, tissue oxygen (ptiO(2)), acid-base balance (ptiCO(2), pH) and CBF measurements, which so far have not lead to clear-cut therapy approaches in the neurointensive care unit. This is partially due to the complex pathophysiology following a wide-range of brain injuries, and the lack of suitable animal models allowing simultaneous, clinically relevant neuromonitoring under controlled conditions. Therefore, a controlled cortical impact (CCI) model in large animals (pig) has been developed. After placement of microdialysis, ptiO(2), temperature and ICP catheters, an uni…

MalePathologymedicine.medical_specialtyMicrodialysisIntracranial PressureSwineGlutamic AcidBrain EdemaBody TemperatureCentral nervous system diseaseText miningOxygen ConsumptionPyruvic AcidmedicineAnimalsClinical significanceLactic AcidCell damageMonitoring Physiologicbusiness.industryGlutamate receptormedicine.diseasePathophysiologyDisease Models Animalmedicine.anatomical_structureGlucoseCerebral cortexAnesthesiaBrain InjuriesNeurology (clinical)businessJournal of neurotrauma
researchProduct

Amygdala pathology in Parkinson's disease.

1994

The amygdala undergoes severe pathological changes during the course of Parkinson's disease (PD). Lewy bodies and Lewy neurites are distributed in a specific manner throughout the nuclear complex. The lesional pattern displays only minor interindividual variation. The most prominent changes occur in the accessory cortical and central nuclei. The cortical, accessory basal and granular nuclei show less severe alterations, while the basal and lateral nuclei, as well as the intercalated cell masses, generally remain uninvolved. The amygdala receives a broad range of afferents, allowing integration of exteroceptive information with interoceptive data. It generates major projections to the isocor…

MalePathologymedicine.medical_specialtyParkinson's diseaseLewy bodyHippocampusParkinson DiseaseBiologyMiddle Agedmedicine.diseaseAmygdalaAmygdalaPathology and Forensic MedicineCellular and Molecular NeuroscienceBasal (phylogenetics)Limbic systemmedicine.anatomical_structureDegenerative diseasemedicineHumansFemaleNeurology (clinical)Prefrontal cortexAgedActa neuropathologica
researchProduct

Neocortical Variation of Abeta Load in Fully Expressed, Pure Alzheimer's Disease

2010

The relationship between amyloid-beta (A beta) deposition and tau-related neurofibrillary changes is a key issue in the pathogenesis of Alzheimer's disease (AD). The aim of this study was to investigate the extent and cortical distribution of A beta and tau pathology, their mutual links and their correlation with the duration of the disease in thirty-nine patients with fully expressed AD. By tau immunohistochemistry, we identified different patterns of distribution of neurofibrillary changes that were ascribed to Braak stage V and VI. The disease duration was longer in patients at Braak stage VI than in those at V. Morphometric analysis carried out in several neocortical areas demonstrated …

MalePathologymedicine.medical_specialtyTau proteinNeocortextau ProteinsPathogenesisSuperior temporal gyrusAlzheimer Diseasemental disordersmedicineHumansSenile plaquesAgedAged 80 and overNeocortexAmyloid beta-PeptidesbiologyGeneral NeuroscienceGeneral MedicinePsychiatry and Mental healthClinical Psychologymedicine.anatomical_structureGene Expression RegulationCerebral cortexbiology.proteinDisease ProgressionFemaleGeriatrics and GerontologyPrimary motor cortexPsychologyNeuroscienceBraak staging
researchProduct

Fine structural features of the cerebral microvasculature in hydrocephalic human infants: correlated clinical observations.

1989

Four of 30 human cerebral cortex biopsies from infants ranging from four days to about ten years treated for hydrocephalus by shunt operations are described paying special attention to the vascular structures. The biopsy specimens were studied in semi-thin and ultrathin sections. Attention is drawn to the role of pinocytotic vesicles found in capillaries and smaller vessels as a possible transcellular route for the hydrocephalic oedema resolution. No intercellular dehiscences or the so called blisters were observed. With the passage of time, the number of membrane bound vesicles increased and arrays of pinocytotic vesicles were discernible both on the abluminal as well as luminal aspect of …

MalePathologymedicine.medical_specialtyVascular transportVacuole03 medical and health sciences0302 clinical medicineCerebrospinal fluidMedicineHumansTranscellularChild030304 developmental biologyCerebral Cortex0303 health sciencesbusiness.industryVesicleMicrocirculationInfant NewbornInfantGeneral MedicineAnatomyMicroscopy Electronmedicine.anatomical_structureCerebral cortexChild PreschoolSurgeryBasal laminaFemaleNeurology (clinical)Pericytebusiness030217 neurology & neurosurgeryHydrocephalusNeurosurgical review
researchProduct

Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)

2016

The respiratory manifestations of eosinophilic granulomatosis with polyangiitis (EGPA) have not been studied in detail.In this retrospective multicentre study, EGPA was defined by asthma, eosinophilia and at least one new onset extra-bronchopulmonary organ manifestation of disease.The study population included 157 patients (mean±sd age 49.4±14.1 years), with a mean±sd blood eosinophil count of 7.4±6.4×109 L−1 at diagnosis. There was a mean±sd of 11.8±18.2 years from the onset of asthma to the diagnosis of EGPA, of 1.4±8.4 years from the first onset of peripheral eosinophilia to the diagnosis of EGPA, and of 7.4±6.4 years from EGPA diagnosis to the final visit. Despite inhaled and oral corti…

MalePediatricsAdministration OralDiseaseChurg-Strauss SyndromeBronchoalveolar LavageSeverity of Illness Index0302 clinical medicineAdrenal Cortex HormonesEosinophilicEosinophiliaAged 80 and overNomenclatureSystemic VasculitisCohortMiddle AgedTerm-follow-upPrognosis3. Good healthRespiratory Function TestsManagementTreatment OutcomeCohortAntineutrophil cytoplasmic antibodiesPopulation studyFemaleFrancemedicine.symptomGranulomatosis with polyangiitisConsensus conferencePulmonary and Respiratory MedicineAdultmedicine.medical_specialtyAdolescentVasculitides[ SDV.EE.SANT ] Life Sciences [q-bio]/Ecology environment/HealthGranulomatosis03 medical and health sciencesYoung AdultEosinophiliamedicineHumansAnti-neutrophil cytoplasmic antibodyAsthmaAgedRetrospective Studies030203 arthritis & rheumatology[SDV.EE.SANT]Life Sciences [q-bio]/Ecology environment/Healthbusiness.industryGranulomatosis with Polyangiitisasthmamedicine.diseaseEosinophils030228 respiratory systemImmunologybusinessTomography X-Ray Computed
researchProduct

A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy.

2013

Despite the existence of therapeutic guidelines, management of multiple sclerosis relapse remains heterogeneous. Optimisation of relapse outcome demands an improved understanding of the neurologist's therapeutic attitude towards relapse management, which is the aim of this study. Neurologists from 13 multiple sclerosis centres completed a questionnaire every time they assessed multiple sclerosis relapses. The questionnaire requested a guided description of the relapse's clinical characteristics and an indication of the prescribed therapy, supported with up to 3 out of 20 suggested reasons. Over 3 months, 368 questionnaires were collected. Median percentage (%) of 21 relapses resulting in a …

MalePediatricsNeurologyCross-sectional studymulti center studyAdrenal Cortex HormoneAdrenal Cortex HormonesRecurrenceSurveys and QuestionnairesMultiple SclerosiCorticosteroidSurveys and QuestionnaireRelapseSurveyNeuroradiologyGeneral MedicineMiddle AgedManagementPsychiatry and Mental healthMethylprednisoloneItalyNeurologyPsychiatry and Mental Healthmultiple sclerosiSettore MED/26 - NeurologiaFemaleNeurosurgerymedicine.drugHumanAdultmedicine.medical_specialtyMultiple SclerosisDermatologyMethylprednisolonemedicineHumansMedical prescriptionCross-Sectional Studietherapybusiness.industryMultiple sclerosismedicine.diseaseManagement of multiple sclerosisCross-Sectional StudiesHealth Care SurveyHealth Care SurveysPhysical therapyNeurology (clinical)business2708
researchProduct

Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study

2017

The natural history and its modulation by treatments administered for immune thrombocytopenia (ITP) in the clinical practice remains unknown. In addition, little information is available on the characteristics and management of ITP in Spain. We conducted an observational, multicenter, registry in 70 Hematology Services from Spain between 2009 and 2011, which included children from 2 months of age and adults with primary ITP or another ITP diagnosed within the last 6 months (platelet count [PC]  484 patients were included (median [Q1, Q3] age 52 [29,74] years, 87.6% adults), 56% women, 10.5% with secondary ITP. Median (Q1, Q3) PC at diagnosis was 12 × 109/l (4, 32); 72% of patients had bleed…

MalePediatricsRegistry studyComorbidity030204 cardiovascular system & hematologycorticosteroids0302 clinical medicineAdrenal Cortex Hormonesimmune system diseaseshemic and lymphatic diseasesRegistriesChildresponseHematologyDisease ManagementImmunoglobulins IntravenousHematologyMiddle AgedClinical PracticeNatural historyPhenotypeTreatment OutcomeIntravenous ImmunoglobulinsChild PreschoolFemaleAlgorithmsAdultmedicine.medical_specialtyAdolescentHemorrhageintravenous immunoglobulinsYoung Adult03 medical and health sciencesImmune systemInternal medicinemedicineHumansAgedPurpura Thrombocytopenic IdiopathicPlatelet Countbusiness.industryInfantImmune thrombocytopeniaImmune thrombocytopeniaSpainObservational studybusinessBiomarkers030215 immunologyHematology
researchProduct